Prostate-Specific Membrane Antigen Targeted Deep Tumor Penetration of Polymer Nanocarriers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prostate-Specific Membrane Antigen Targeted Deep Tumor Penetration of Polymer Nanocarriers

Published:2022-11-01 Issue:45 Volume:14 Page:50569-50582
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Meher Niranjan¹^ORCID,Ashley Gary W.²,Bidkar Anil P.¹^ORCID,Dhrona Suchi¹,Fong Cyril¹,Fontaine Shaun D.²,Beckford Vera Denis R.¹,Wilson David M.¹³^ORCID,Seo Youngho¹³,Santi Daniel V.²,VanBrocklin Henry F.¹³^ORCID,Flavell Robert R.¹³⁴^ORCID

Affiliation:

1. Department of Radiology and Biomedical Imaging, University of California, San Francisco, California 94143, United States

2. ProLynx Inc., San Francisco, California 94158, United States

3. Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California 94143-0981, United States

4. Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158-2517, United States

Funder

U.S. Department of Defense

National Institutes of Health

Prostate Cancer Foundation

Precision Imaging of Cancer Therapy Program

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.2c15095

Reference62 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

3. Current use of PSMA–PET in prostate cancer management

4. Detection Efficacy of 18F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy

5. Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personalized Cancer Nanomedicine: Overcoming Biological Barriers for Intracellular Delivery of Biopharmaceuticals;Advanced Materials;2023-12-31

2. Unsteady nano-magnetic drug dispersion for pulsatile Darcy flow through microvessel with drug elimination phenomena;Physics of Fluids;2023-10-01

3. Unleashing novel horizons in advanced prostate cancer treatment: investigating the potential of prostate specific membrane antigen-targeted nanomedicine-based combination therapy;Frontiers in Immunology;2023-09-19

4. Enzyme/pH Dual-Responsive Size-Shrinkable Nanocomposites for Tumor Penetration and Enhanced Multimodal Cancer Therapy;ACS Applied Nano Materials;2023-06-30

5. Nanoparticle-Based Radioconjugates for Targeted Imaging and Therapy of Prostate Cancer;Molecules;2023-05-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3